Skip to content
Screener

Donaldson Company DCI Life Sciences Segment — Cost of Sales

Other segment segments

Mobile Solutions Segment
$422.6M+6.6%
Industrial Solutions Segment
$179.2M+5.7%

Similar metrics at other companies

IR
IRPrecision and Science Technologies — Cost of Sales
$206M+9.2%
Home Depot logo
HDPrimary Segment — Cost of Sales
$24.75B+1.5%
Medifast logo
MEDOptavia Segment — Cost of Sales
$24.29M-22.9%
NAG
NAGEIngredients segment — Cost of Sales
$3.56M+14.6%
NAG
NAGEPharmaceuticals segment — Cost of Sales
$0
Novavax logo
NVAXReportable Segment — Cost of Sales
$14.25M-7.0%

Other financials

Income statement

See full
Revenue$995.1M+5.9%
Gross profit$333.4M+3.6%
Operating income$155.3M+77.7%
Net income$118.1M+104%
EPS (diluted)$1.00+108%

Balance sheet

See full
Cash & equivalents$204.1M+14.3%
Total debt$601.9M-16.7%
Total equity$1.7B+15.8%
Total assets$3.1B+3.0%

Cash flow

See full
Operating cash flow$135.4M+54.4%
CapEx$23.3M+42.9%
Free cash flow$112.1M+57.0%

Valuation

See full
Market cap$11.27B+34.1%
Enterprise value$11.67B+30.4%
P/E25.7×+2.8×
P/S+0.7×

Profitability

See full
Gross margin34.2%-1.0pp
Operating margin15.1%+1.7pp
Net margin11.5%+1.6pp
FCF margin10.3%+2.1pp

Returns & leverage

See full
Return on equity27.8%+3.2pp
Debt / equity0.4×-0.1×
Current ratio2.4×+0.4×

Where this comes from

Reported directly by Donaldson Company in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The source filing: Donaldson Company’s 10-Q, filed June 2, 2026.

Filed
Jun 2, 2026, 11:28 AM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0000029644-26-000052
Three Months Ended April 30, 2026Mobile Solutions SegmentIndustrial Solutions SegmentLife Sciences SegmentTotal SegmentCorporate and Unallocated (1)Total Company
Net sales$629.9$281.7$83.5$995.1$995.1
Cost of sales422.6179.249.2
Other segment items (2)80.364.827.5
Earnings (loss) before income taxes$127.0$37.7$6.8$171.5$(16.7)$154.8
Equity earnings in unconsolidated affiliates$3.5$3.5
Nine Months Ended April 30, 2026
Net sales$1,784.8$799.2$242.8$2,826.8$2,826.8
Cost of sales1,202.7503.0140.4

Item 1. Financial Statements

FAQ

What is Donaldson Company's life sciences segment — cost of sales?
Donaldson Company (DCI) reported life sciences segment — cost of sales of $49.2M in Q1 2026.
How has Donaldson Company's life sciences segment — cost of sales changed year-over-year?
Donaldson Company's life sciences segment — cost of sales increased by 7.9% year-over-year, from $45.6M to $49.2M.
What is the long-term trend for Donaldson Company's life sciences segment — cost of sales?
Over 2 years (2023 to 2025), Donaldson Company's life sciences segment — cost of sales has grown at a 14.1% compound annual growth rate (CAGR), from $136.8M to $178.1M.
What does life sciences segment — cost of sales mean?
Includes all direct costs associated with the production and delivery of filtration systems and parts within the Life Sciences segment, such as raw materials, direct labor, and manufacturing overhead. This metric is critical for evaluating the segment's gross margin efficiency.

Ask your AI about Donaldson Company's life sciences segment — cost of sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude